Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Shanghai Pharma(601607) the Revenue is 72.21 B (+1.95%), Beat estimate;the EBIT is 3.225 B (-31.19%), Beat estimate;the EPS is 0.568 (-32.42%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
72.21B1.95%
68.49B3.30%
+3.72B5.25%
EBITExceed expectations
3.23B31.19%
2.22B52.72%
+1.01B21.53%
EPSExceed expectations
0.567732.42%
0.496240.93%
+0.07158.51%
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf